enzon pharmaceuticals inc
(ENZN:Consolidated Issue listed on NASDAQ Capital Market)
Timothy G. Daly
Consultant, Enzon Pharmaceuticals Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
As of Fiscal Year 2013
Mr. Timothy G. Daly served as the Chief Accounting Officer, Vice President and Controller at Enzon Pharmaceuticals Inc. from December 19, 2011 to August 9, 2013 and also served as its Principal Financial Officer until August 9, 2013. Mr. Daly has more than 12 years of experience in the biotech and pharmaceutical healthcare industry. Since 2006, he served as a Director of Finance at ImClone Systems, a wholly owned subsidiary of Eli Lilly and Company. During his tenure ...
20 Kingsbridge RoadPhone: 732-980-4500
Piscataway, New Jersey 08854
Board Members Memberships*There is no Board Members Memberships data available.
|Howard W. Robin||Chief Executive Officer, President and Director|
|Judith Greciet Ph.D., Pharmacy||Chief Executive Officer, Director and Member of Corporate Development Committee|
|William J. Polvino M.D.||Chief Executive Officer and President|
Veloxis Pharmaceuticals A/S
|William John Edward Burt DPhil||Chief Executive Officer and Executive Director|
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|